It is precisely this axis that KLOW adds over GLOW as an additional anti-inflammatory tripeptide
It is widely studied for its potential roles in tissue regeneration, cellular repair, angiogenesis, and gastrointestinal protection within controlled laboratory settings
The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide
The exercise-mimetic angle also deserves continued development
Patients experiencing neurological symptoms such as paresthesias, balance problems, or cognitive changes warrant prompt B12 assessment with same-day clinical evaluation for severe or rapidly progressive symptoms